Creative Medical Technology Holdings Inc (CELZ) Stock Price, Quote & News

Company Profile

Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness. It develops AlloStem (CELZ-201-DDT), a allogenic human perinatal tissue derived cell program, ImmCelz (CELZ-100), a personalized super...

Industry: Biotechnology

Sector: Healthcare

Phone: (480) 399-2822

Website: www.creativemedicaltechnology.com

Address:

211 East Osborn Road, Phoenix, United States

wokazn Oct. 3 at 3:30 PM

$CELZ I really like this one from Tim this morning! https://www.linkedin.com/posts/creative-medical-technology-holdings-inc_celz-diabetesinnovation-type1diabetes-activity-7379888035456438272-0x0Q?utm_source=share&utm_medium=member_android&rcm=ACoAADG-GcwBtYcdWUyYcGQifsZG7xLS4qRLp3M

1 · Reply

Peterb3346 Oct. 3 at 9:02 AM

$CELZ Certainly not soaring like it should on all of the patents. Holding until something changes, but this is only a portion of my portfolio, lots of artificial intelligence investment and some other stuff as well. Still believe that this will 100x eventually!

0 · Reply

HouseOfTheDragons Oct. 3 at 2:36 AM

Looks like volume & momentum could be shifting in to ASTC! Tiny float getting a lot of attention and could explode upwards on volume. Watchers on ASTC are growing very fast and it could be the potential top runner for this week! Starting its 300% run - keep it on watch! Also watching for breakout: $CELZ $CING $CISO $CRKN R

0 · Reply

ka1954 Oct. 2 at 6:53 PM

$CELZ too many like me frustrated here. how long we r just going to sit here and just do nothing

1 · Reply

wokazn Sep. 29 at 3:06 PM

$CELZ another positive post from Tim! https://www.linkedin.com/posts/creative-medical-technology-holdings-inc_nasdaq-celz-activity-7378438160554430465-oXe4?utm_source=share&utm_medium=member_android&rcm=ACoAADG-GcwBtYcdWUyYcGQifsZG7xLS4qRLp3M

1 · Reply

LegendaryCharts Sep. 28 at 6:22 PM

$PAVS Massive buy orders on Friday on this low float, Looks like this thing might be squeezing up. Top watch for me! $WINT Recent form 8k was bullish $CELZ patent value growing $CRWV swinging calls

0 · Reply

wokazn Sep. 26 at 3:55 PM

$CELZ positive post from Tim! https://www.linkedin.com/posts/creative-medical-technology-holdings-inc_celz-nassdaq-creativemedical-activity-7377318619887603712-Gwqc?utm_source=share&utm_medium=member_android&rcm=ACoAADG-GcwBtYcdWUyYcGQifsZG7xLS4qRLp3M

0 · Reply

wokazn Sep. 25 at 4:21 PM

$CELZ Celz has the most powerful single source of cells. The current trials will prove its power in its form, while future trials will show its power utilizing advanced technologies! Advanced technology (iPSCelz) IND will be announced!

1 · Reply

ka1954 Sep. 24 at 6:45 PM

$CELZ people are just getting too frustrated with this fucking stock. i wish this just went to 6 already so some of us could have exited

2 · Reply

BoilermakerB Sep. 24 at 2:47 PM

$CELZ stuck in no mans land between trials and FDA approval....lol

0 · Reply

Creative Medical Technology Holdings Receives Notice of Allowance for the Prevention and/or Treatment of Type 1 Diabetes Using Modulated Immune Cells

Jul 11, 2025, 8:01 AM EDT - 3 months ago

Creative Medical Technology Holdings Receives Notice of Allowance for ImmCelz™ for Treatment of Heart Failure and/or Post Infarct Pathological Remodeling

Mar 20, 2025, 7:50 AM EDT - 7 months ago

Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain

Mar 6, 2025, 8:10 AM EST - 7 months ago

Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross Proceeds

Feb 14, 2025, 7:00 AM EST - 8 months ago

Creative Medical Technology Holdings Announces Mid-Term Follow-up Study Data Reporting Significant Reduction in Opioid Use by Chronic Lower Back Pain Patients Undergoing StemSpine® Procedure using AlloStem™

Feb 11, 2025, 9:25 AM EST - 8 months ago

Creative Medical Technology Reports Positive One-Year Results for AlloStem™ Type 2 Diabetes Program

Feb 5, 2025, 8:25 AM EST - 8 months ago

Creative Medical Technology Holdings Expands Collaboration with Greenstone Biosciences to Accelerate iPSCelz Pipeline Development

Jan 30, 2025, 9:25 AM EST - 8 months ago

Creative Medical Technology Holdings Announces Positive Initial Safety, Tolerability, and Efficacy Data from First Cohort in Phase 1/2 Trial of CELZ-201-DDT for Chronic Back Pain

Nov 25, 2024, 9:03 AM EST - 11 months ago

Top 3 Real Estate Stocks That May Explode In Q4

OPI WHLR

Nov 13, 2024, 9:00 AM EST - 11 months ago

Creative Medical Technology Holdings, Inc. Advances FDA Cleared ADAPT Clinical Trial with Positive Independent Review, Validating the Safety and Potential of CELZ-201 for Chronic Lower Back Pain Treatment

Jul 24, 2024, 9:00 AM EDT - 1 year ago

Creative Medical Technology Holdings Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure Utilizing its Validated iPSC Personalized Medicine Program

Jul 10, 2024, 8:30 AM EDT - 1 year ago

Creative Medical Technology Holdings Provides Corporate Update

Jun 24, 2024, 8:30 AM EDT - 1 year ago

Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin

Mar 7, 2024, 9:15 AM EST - 1 year ago

Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access

Mar 6, 2024, 7:00 AM EST - 1 year ago

Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy

Dec 20, 2023, 9:35 AM EST - 1 year ago

Creative Medical Technology Holdings (NASDAQ:CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem(TM) For Addressing Chronic Lower Back Pain

Oct 10, 2023, 8:00 AM EDT - 2 years ago

Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain

Sep 19, 2023, 8:00 AM EDT - 2 years ago

Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain

Aug 24, 2023, 10:45 AM EDT - 2 years ago

What Is Allogeneic Cell Therapy, And What's Driving This Market's 25%+ Annual Global Growth?

Jul 14, 2023, 9:00 AM EDT - 2 years ago

The Immunotherapy Market is Expected to Surpass $351.56 Billion by 2030 - Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) is Contributing to this Growth

Jul 13, 2023, 9:00 AM EDT - 2 years ago

Creative Medical Technology Reports Advancements In Regenerative Medicine And Improvements In Financial Position In Corporate Update

Jun 28, 2023, 8:00 AM EDT - 2 years ago

Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements

Jun 12, 2023, 8:01 AM EDT - 2 years ago

Creative Medical Technology Announces $2 Million Share Repurchase Program

Jun 9, 2023, 12:30 PM EDT - 2 years ago

Creative Medical Technology Holdings Announces Reverse Stock Split

May 31, 2023, 8:00 AM EDT - 2 years ago

Creative Medical Technology Holdings Announces Successful Completion of the First Phase of its Program with Greenstone Biosciences, Inc. to Develop Next Generation iPSC Pipeline for ImmCelz® Immunotherapy Platform

May 22, 2023, 8:30 AM EDT - 2 years ago

Creative Medical Technology Holdings Announces Next Milestone Achievements in ImmCelz® Platform Development

May 18, 2023, 8:00 AM EDT - 2 years ago

Creative Medical Technology Holdings Announces Positive Top-Line Study Results for Chronic Lower Back Pain Utilizing its StemSpine® Procedure Using AlloStem™ Allogenic Cell Line

Apr 12, 2023, 8:00 AM EDT - 2 years ago

Creative Medical Technology Announces Positive Top-Line Results for Type 2 Diabetes Study

Apr 4, 2023, 8:00 AM EDT - 2 years ago

Creative Medical Technology Holdings Announces Filing of 2022 Form 10-K and Provides Business Update

Mar 23, 2023, 8:00 AM EDT - 2 years ago

Creative Medical Technology Files Orphan Drug Designation Application with the U.S. FDA Using the ImmCelz® Platform for the Treatment of Brittle Type 1 Diabetes

Mar 21, 2023, 8:00 AM EDT - 2 years ago

Creative Medical Technology Holdings Announces Key Milestones Regarding ImmCelz® Platform Development

Mar 7, 2023, 8:00 AM EST - 2 years ago

Creative Medical Technology Holdings Engages Highly Respected International CRO for Phase 1 / 2 Clinical Trial to Treat Type 1 Diabetes Using CELZ-201

Feb 14, 2023, 8:00 AM EST - 2 years ago

Three Year Follow-Up Results Confirm Efficacy of StemSpine® Procedure for Treating Chronic Lower Back Pain, with No Serious Adverse Effects

Feb 8, 2023, 8:00 AM EST - 2 years ago

Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of Novel Cell Therapy for the Treatment of Type 1 Diabetes

Nov 3, 2022, 7:30 AM EDT - 3 years ago

Creative Medical Technology Holdings Announces FDA Clearance of Investigational New Drug (IND) Application for AlloStem™, a Novel Cell Therapy for the Treatment of Type 1 Diabetes

Oct 20, 2022, 8:00 AM EDT - 3 years ago

Creative Medical Technology Holdings Develops AlloStem™ Clinical Cell Line

Sep 26, 2022, 8:00 AM EDT - 3 years ago

Creative Medical Technology Announces Peer Reviewed Publication of Positive Results for StemSpine® Study

Jul 28, 2022, 7:30 AM EDT - 3 years ago

Creative Medical Technology Announces Positive Top-Line Results for OvaStem® Pilot Study

Jun 15, 2022, 8:30 AM EDT - 3 years ago

Creative Medical Technology Holdings Announces Agreement with Greenstone Biosciences, Inc. for Development of a Next Generation iPSC Pipeline for its ImmCelz® Immunotherapy Platform

Apr 29, 2022, 8:40 AM EDT - 3 years ago

Creative Medical Technology Announces $17 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Apr 20, 2022, 8:30 AM EDT - 3 years ago

Creative Medical Technology Announces Progress in Developing a Reproducible Clinical Grade of the Company's ImmCelz® Product

Apr 12, 2022, 8:30 AM EDT - 3 years ago

Creative Medical Technology to Showcase CaverStem® at American Urological Association Annual Meeting - Largest and Most Prominent Gathering of Urologists in the World

Mar 23, 2022, 10:15 AM EDT - 3 years ago

Why Creative Medical Technology Shares Are Soaring

Mar 23, 2022, 10:15 AM EDT - 3 years ago

Creative Medical Shares Soar On Positive Data from StemSpine Pilot Study

Mar 23, 2022, 8:30 AM EDT - 3 years ago

Creative Medical Technology Announces Positive Top-Line Results for StemSpine® Pilot Study

Mar 8, 2022, 8:30 AM EST - 3 years ago

Creative Medical Technology to Participate in the 34th Annual Roth Conference

Mar 2, 2022, 8:30 AM EST - 3 years ago

Creative Medical Technology Appoints Sahil Nock as Chief Commercial Officer

Dec 3, 2021, 4:00 AM EST - 4 years ago

Creative Medical Technology Holdings, Inc. Prices $16 Million Public Offering and Uplisting to the Nasdaq Capital Market

Nov 9, 2021, 4:45 PM EST - 4 years ago

Creative Medical Technology Holdings Announces Implementation of Reverse Stock Split in Preparation for Planned Uplisting to The Nasdaq Capital Market

wokazn Oct. 3 at 3:30 PM

1 · Reply

Peterb3346 Oct. 3 at 9:02 AM

0 · Reply

HouseOfTheDragons Oct. 3 at 2:36 AM

0 · Reply

ka1954 Oct. 2 at 6:53 PM

$CELZ too many like me frustrated here. how long we r just going to sit here and just do nothing

1 · Reply

wokazn Sep. 29 at 3:06 PM

1 · Reply

LegendaryCharts Sep. 28 at 6:22 PM

$PAVS Massive buy orders on Friday on this low float, Looks like this thing might be squeezing up. Top watch for me! $WINT Recent form 8k was bullish $CELZ patent value growing $CRWV swinging calls

0 · Reply

wokazn Sep. 26 at 3:55 PM

0 · Reply

wokazn Sep. 25 at 4:21 PM

1 · Reply

ka1954 Sep. 24 at 6:45 PM

$CELZ people are just getting too frustrated with this fucking stock. i wish this just went to 6 already so some of us could have exited

2 · Reply

BoilermakerB Sep. 24 at 2:47 PM

$CELZ stuck in no mans land between trials and FDA approval....lol

0 · Reply

ka1954 Sep. 24 at 2:26 PM

$CELZ why this fucking stock can't just go up to 6+ so some of us can exit? LOL

0 · Reply

CG2260 Sep. 24 at 2:09 PM

$CELZ diabetes News is so overdue

0 · Reply

BoilermakerB Sep. 23 at 3:12 PM

$CELZ Tim.....anything?

0 · Reply

Peterb3346 Sep. 23 at 2:40 PM

$CELZ needs more good news and more income to generate volume.

0 · Reply

luxm3 Sep. 23 at 2:13 PM

$CELZ need volume baby....

0 · Reply

ka1954 Sep. 19 at 10:05 PM

$CELZ great you sold, we don't need people like you in this stock !!!

1 · Reply

dice2022 Sep. 19 at 3:22 PM

$CELZ I think I’m going to $SELZ

2 · Reply

CallMeEddieMush Sep. 18 at 7:15 PM

$CELZ I guess this is still a scam

1 · Reply

BoilermakerB Sep. 18 at 7:08 PM

$CELZ can we get an update on the FDA fast track candidates Tim? Please amd thank you.

0 · Reply

Kjstock Sep. 18 at 12:33 PM

$CELZ kind of wish this was coming from Celz… https://www.sciencedaily.com/releases/2025/09/250916221821.htm

2 · Reply

Peterb3346 Sep. 18 at 10:26 AM

$CELZ let's see that 6.90 again on the way to blowing way past it.

0 · Reply

David_M_ Sep. 18 at 8:13 AM

$CELZ

0 · Reply

Market Cap	8.35M
Revenue (ttm)	10,000.00
Net Income (ttm)	-5.49M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-54,900.00%
Debt to Equity Ratio	0.00

Volume	43,000
Avg Vol	86,282
Day's Range	N/A - N/A
Shares Out	2.58M
Stochastic %K	35%
Beta	2.06
Analysts	Sell
Price Target	$20.00